{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:09:05Z","timestamp":1792786145358,"version":"4.5.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"38","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"First Affiliated Hospital of Chengdu Medical College","award":["CYFY2021YB07"],"award-info":[{"award-number":["CYFY2021YB07"]}],"id":[{"id":"https:\/\/ror.org\/03jckbw05","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Key project of Chengdu Medical College-The First Affiliated Hospital of Traditional Chinese Medicine of chengdu Medical college Joint Scientific Research Fund","award":["2022LHZYYB-16"],"award-info":[{"award-number":["2022LHZYYB-16"]}],"id":[{"id":"https:\/\/ror.org\/01c4jmp52","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Scientific Research Project of Chengdu Medical College","award":["CYZYB25-04"],"award-info":[{"award-number":["CYZYB25-04"]}],"id":[{"id":"https:\/\/ror.org\/01c4jmp52","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,18]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Adherence to urate-lowering therapy (ULT) is crucial for gout management, yet it remains suboptimal worldwide, particularly in China where relevant data are scarce. This study investigates the prevalence and predictors of medication adherence among Chinese gout patients receiving ULT over a 1-year period. A 1-year prospective cohort study was conducted among gout patients prescribed ULT at a single center. Adherence was assessed using the Compliance Questionnaire in Rheumatology at 6 and 12 months, with scores \u226580% defining adherence. Predictors encompassing socioeconomic, therapy-related, patient-related, condition-related, and healthcare system\u2013related factors were analyzed using multiple linear regression models. Among 141 recruited patients (96.5% male), the adherence prevalence was 8.3% (11\/133) at 6 months and 7.1% (9\/127) at 1 year. In multiple linear regression, a higher gout knowledge (Gout Knowledge Questionnaire) score was independently associated with better adherence at 6 months (\u03b2\u2005=\u2005\u22120.223,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.001). At 1 year, taking urate-lowering agent in the past week was the sole independent predictor (\u03b2\u2005=\u20050.178,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.014). Medication adherence to ULT among gout patients in this Chinese cohort is notably low and declines over time. Patient knowledge and recent medication-taking behavior are key modifiable predictors. Interventions should be targeted within the first 6 months of therapy.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050676","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:01:27Z","timestamp":1789750887000},"page":"e50676","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Multilevel factors predicting medication adherence among gout patients in China"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5580-2957","authenticated-orcid":false,"given":"Haiyan","family":"Jiang","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Immunology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanda","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Shanghai University of Medicine & Health Sciences, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0363-0060","authenticated-orcid":false,"given":"Xuan","family":"Lei","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Chengdu Medical College, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9468-5957","authenticated-orcid":false,"given":"Ting","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1909-2311","authenticated-orcid":false,"given":"Xiran","family":"Luo","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Chengdu Medical College, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1916-4716","authenticated-orcid":false,"given":"Weiyu","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Chengdu Medical College, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1373-6953","authenticated-orcid":false,"given":"Shuya","family":"Xiong","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Chengdu Medical College, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3989-8849","authenticated-orcid":false,"given":"Rong","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Chengdu Medical College, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjun","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6813-0878","authenticated-orcid":false,"given":"Tao","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9551-1525","authenticated-orcid":false,"given":"Liwen","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxia","family":"Ran","sequence":"additional","affiliation":[{"name":"Department of Medical Affairs, The People\u2019s Hospital of Jianyang City, Jianyang, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zepeng","family":"Lai","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Chengdu Medical College, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6303-2964","authenticated-orcid":false,"given":"Yapeng","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China"},{"name":"School of Clinical Medicine, Chengdu Medical College, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260922","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","article-title":"Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors.","volume":"16","author":"Dehlin","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"R2-20260922","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/annrheumdis-2011-200801","article-title":"Patient and provider barriers to effective management of gout in general practice: a qualitative study.","volume":"71","author":"Spencer","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R3-20260922","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10389-017-0812-5","article-title":"The prevalence of gout in mainland China from 2000 to 2016: a systematic review and meta-analysis.","volume":"25","author":"Chen","year":"2017","journal-title":"J Public Health"},{"key":"R4-20260922","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13075-015-0522-8","article-title":"Epidemiology and management of gout in Taiwan: a nationwide population study.","volume":"17","author":"Kuo","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"R5-20260922","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","article-title":"Gout.","volume":"397","author":"Dalbeth","year":"2021","journal-title":"Lancet"},{"key":"R6-20260922","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3899\/jrheum.140588","article-title":"Modifiable factors associated with allopurinol adherence and outcomes among patients with gout in an integrated healthcare system.","volume":"42","author":"Nazia","year":"2015","journal-title":"J Rheumatol"},{"key":"R7-20260922","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/art.41247","article-title":"2020 American College of Rheumatology guideline for the management of Gout.","volume":"72","author":"FitzGerald John","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"R8-20260922","doi-asserted-by":"crossref","first-page":"e8532","DOI":"10.1097\/MD.0000000000008532","article-title":"Adherence to gout management recommendations of Chinese patients.","volume":"96","author":"Sheng","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"R9-20260922","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/acr.22336","article-title":"Medication adherence in gout: a systematic review.","volume":"66","author":"De Vera","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R10-20260922","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1093\/rheumatology\/key155","article-title":"Medication adherence among gout patients initiated allopurinol: a retrospective cohort study in the Clinical Practice Research Datalink (CPRD).","volume":"57","author":"Scheepers","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"R11-20260922","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10067-014-2823-8","article-title":"Adherence and persistence to urate-lowering therapies in the Irish setting.","volume":"35","author":"McGowan","year":"2016","journal-title":"Clin Rheumatol"},{"key":"R12-20260922","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/RHU.0000000000002177","article-title":"Allopurinol adherence in US patients with Gout: analysis of the Medical Expenditure Panel Survey, 2018-2021.","volume":"31","author":"Riggs","year":"2025","journal-title":"J Clin Rheumatol"},{"key":"R13-20260922","doi-asserted-by":"crossref","first-page":"413","DOI":"10.55730\/1300-0144.5985","article-title":"Evaluation of treatment compliance in gout patients: a patient-centered study.","volume":"55","author":"G\u00f6rg\u00fcl\u00fc","year":"2025","journal-title":"Turk J Med Sci"},{"key":"R14-20260922","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1474-5151(03)00091-4","article-title":"Adherence to long-term therapies: evidence for action.","volume":"2","author":"De Geest","year":"2003","journal-title":"Eur J Cardiovasc Nurs"},{"key":"R15-20260922","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00296-017-3746-x","article-title":"The rate of adherence to urate-lowering therapy and associated factors in Chinese gout patients: a cross-sectional study.","volume":"37","author":"Yin","year":"2017","journal-title":"Rheumatol Int"},{"key":"R16-20260922","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1002\/art.39254","article-title":"2015 Gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative.","volume":"67","author":"Neogi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R17-20260922","first-page":"2469","article-title":"The compliance-questionnaire-rheumatology compared with electronic medication event monitoring: a validation study.","volume":"30","author":"de Klerk","year":"2003","journal-title":"J Rheumatol"},{"key":"R18-20260922","first-page":"2635","article-title":"Development of a questionnaire to investigate patient compliance with antirheumatic drug therapy.","volume":"26","author":"Klerk","year":"1999","journal-title":"J Rheumatol"},{"key":"R20-20260922","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1471-2474-13-174","article-title":"Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout.","volume":"13","author":"Dalbeth","year":"2012","journal-title":"BMC Musculoskelet Disord"},{"key":"R21-20260922","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/RHU.0b013e318228b4e2","article-title":"Development and evaluation of a survey of gout patients concerning their knowledge about gout.","volume":"17","author":"Zhang","year":"2011","journal-title":"J Clin Rheumatol"},{"key":"R22-20260922","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"R24-20260922","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure.","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"R26-20260922","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7.","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Internal Med Arch Intern Med"},{"key":"R27-20260922","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/ijcp.12604","article-title":"Allopurinol adherence among patients with gout: an Italian general practice database study.","volume":"69","author":"Mantarro","year":"2015","journal-title":"Int J Clin Pract"},{"key":"R28-20260922","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s40744-020-00249-w","article-title":"High rate of adherence to urate-lowering treatment in patients with gout: who\u2019s to blame?","volume":"7","author":"Perez-Ruiz","year":"2020","journal-title":"Rheumatol Ther"},{"key":"R29-20260922","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/rheumatology\/keae514","article-title":"Non-adherence to urate lowering therapy in gout after 5 years is related to poor outcomes: results from the NOR-Gout study.","volume":"64","author":"Uhlig","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"R30-20260922","doi-asserted-by":"crossref","first-page":"102523","DOI":"10.1016\/j.autrev.2020.102523","article-title":"COVID-19 infection and rheumatoid arthritis: faraway, so close!","volume":"19","author":"Favalli","year":"2020","journal-title":"Autoimmun Rev"},{"key":"R31-20260922","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/acr.24257","article-title":"Capturing patient-reported outcomes during the COVID-19 pandemic: development of the COVID-19 global rheumatology alliance patient experience survey.","volume":"72","author":"Sirotich","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R32-20260922","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/acr2.11148","article-title":"Experiences of patients with rheumatic diseases in the United States during early days of the COVID-19 pandemic.","volume":"2","author":"Kaleb","year":"2020","journal-title":"ACR Open Rheumatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050676","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:03:13Z","timestamp":1790100193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050676"}},"subtitle":["A 1\u2011year prospective cohort study"],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":29,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050676","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"2026-01-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}